About Sachin Shah, PharmD, FACC, FAHA
Dr. Sachin A. Shah is a healthcare leader dedicated to science serving humanity. His passion for service began in middle school volunteering in Tanzania and has evolved into groundbreaking work in cardiovascular safety, non-invasive heart therapies (EECP), and medication ingredient transparency. Currently, he advocates for ethical healthcare, empowering patients with Alpha-gal Syndrome, and those with religious or dietary concerns, to make informed choices. As a key driver behind an FDA Citizen Petition, Sachin is redefining healthcare with integrity, compassion, and scientific rigor. Read his full story below.
His Story
Dr. Sachin A. Shah’s life and work are guided by a profound sense of service, inspired by His Holiness Mahant Swami Maharaj, who, at 92, continues to dedicate his life to the betterment of others. This deep-rooted commitment to humanity took shape early in Sachin’s life and has since become the foundation of his mission.
As a middle school student, Sachin’s worldview was profoundly shaped by his volunteer work at the Nunge Leprosy Village in Tanzania, where he helped rebuild shelters, farms, and establish a clean water supply for an isolated community in need. His passion for service continued as he played a key role in organizing Tanzania’s first Terry Fox Run, raising over a million shillings to support cancer research—a milestone event honored by former President Ali Hasan Mwinyi.
Sachin went on to earn his Doctorate in Pharmacy from the Massachusetts College of Pharmacy and Health Sciences (Boston, MA, USA) and later completed a cardiovascular pharmacotherapy fellowship at the University of Connecticut/Hartford Hospital (Hartford, CT, USA). Despite an early career trajectory towards the pharmaceutical industry—including internships at Pfizer and Johnson & Johnson—his spiritual mentor’s guidance led him to academia, where he believed he could create greater societal impact.
Guided by the belief that science should serve humanity, Sachin has dedicated his career to challenging conventional healthcare practices when they fail to prioritize patient well-being. He has fearlessly pursued research and advocacy in areas often overlooked by mainstream healthcare, including his widely recognized research on the cardiovascular safety of energy drinks and dietary supplements—work that has challenged industry norms to protect public health.
His commitment to ethical, non-invasive treatment options led him to Enhanced External Counterpulsation (EECP), a therapy described by Reader’s Digest as a “natural bypass” for the heart. For over 15 years, he has been at the forefront of EECP research, ensuring that patients with heart disease have access to safer alternatives to invasive procedures.
Most recently, Sachin has taken on the critical issue of medication safety and ingredient transparency. Recognizing the challenges faced by patients with alpha-gal syndrome and those with religious, dietary, ethical, or environmental concerns, he has become a key advocate for full disclosure of pharmaceutical ingredients. He played a pivotal role in driving an FDA Citizen Petition demanding greater transparency in pharmaceutical labeling, ensuring that patients can make informed healthcare choices aligned with their needs and values.
Through Pill Clarity, Sachin continues his lifelong mission—bridging the gap between science, ethics, and patient well-being. His work is not just about medicine; it is about empowering people, protecting lives, and redefining healthcare with compassion and integrity.
